Current stage-Stage III - Page 6 of 9 Posts on Medivizor
Navigation Menu

Current stage-Stage III Posts on Medivizor

Vemurafenib combined with cobimetinib is an effective treatment option for BRAF-mutant melanoma

Posted by on Nov 7, 2016 in Melanoma | 0 comments

In a nutshell This study examined the effectiveness and safety of the combined treatment of vemurafenib (Zelboraf) with cobimetinib (Cotellic) in advanced melanoma. Researchers concluded that this combination treatment is an important therapy option for patients with advanced melanoma. Some background Some melanoma patients have a...

Read More

Post-surgery anastomotic leakage and stenosis is associated with pre-surgery radiation therapy

Posted by on Nov 7, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the impact of radiation therapy (RT) followed by surgery in rectal cancer patients. Researchers suggested that RT increases the risk of anastomotic leakage and narrowing (stenosis) after rectal cancer. Some background Surgery for rectal cancer often involves the rejoining of two parts of intestine. Anastomotic...

Read More

Lateral pelvic lymph node metastasis has a prognostic role in rectal cancer

Posted by on Sep 12, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the prognostic role of extramural tumor deposits (clusters of cancer cells not attached to the main tumor) in the pelvic area in rectal cancer. Researchers suggested that tumor deposits near the pelvic lymph nodes was a useful predictor of prognosis. Some background Colorectal cancer is one of the most common...

Read More

Invasive breast cancer: a review

Posted by on Aug 9, 2016 in Breast cancer | 0 comments

In a nutshell This review outlined the recommended treatment options for invasive breast cancer.  Some background Breast cancer is the most commonly diagnosed cancer in the world and it is the leading cause of cancer-related death in women. Breast cancer often begins in the milk ducts and lobules. In invasive breast cancer, the cancer moves...

Read More

LDH as an early predictor of cancer survival

Posted by on Feb 8, 2016 in Melanoma | 0 comments

In a nutshell This study investigated the relationship between lactate dehydrogenase (LDH) levels and cancer-specific survival. Researchers concluded that LDH can be used as an early indicator of cancer outcomes. Some background Early cancer detection methods have significantly improved cancer survival rates. There is increasing evidence to...

Read More

In what order should chemotherapies be delivered?

Posted by on Oct 25, 2015 in Colorectal cancer | 0 comments

In a nutshell This review discussed the use of second-line chemotherapy (therapy after disease progression despite initial treatment) in colorectal cancer. Some background Patients with advanced (spread to lymph nodes and beyond) colorectal cancer often require a second round of chemotherapy following their first treatments. The use of multiple...

Read More

Ipilimumab-induced hypophysitis in advanced melanoma

Posted by on Oct 11, 2015 in Melanoma | 0 comments

In a nutshell The authors analyzed the occurrence, management and risk factors of hypophysitis (a complication of the immune system following ipilimumab [Yervoy] therapy) in advanced melanoma patients.   Some background In advanced melanoma (stage III/IV), cancer spreads rapidly from the skin to other parts of the body....

Read More

The effects of chemotherapy on thyroid function

Posted by on May 12, 2015 in Breast cancer | 2 comments

In a nutshell The authors aimed to assess whether chemotherapy has an impact on thyroid function.  Some background The thyroid is an endocrine gland (tissue that releases hormones) found in the neck. It controls how quickly the body uses energy used in the body, how the body reacts to other hormones and makes proteins. Thyroid hormones can...

Read More